9 3 7159 (Pergolide Mesylate 0.25 mg)
Pill with imprint 9 3 7159 is Yellow, Elliptical / Oval and has been identified as Pergolide Mesylate 0.25 mg. It is supplied by Teva Pharmaceuticals USA.
Pergolide is used in the treatment of parkinson's disease; hyperprolactinemia; tourette's syndrome and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Pergolide 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 9 3 7159
Pergolide Mesylate
- Imprint:
- 9 3 7159
- Strength:
- 0.25 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7159
More about pergolide
- Pergolide Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
